Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 13, Status: Authorised
Day 80 assessment report - Non-clinical template with guidance Rev. 03.25 - Revamp
Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026
Streamlining development and assessment of biosimilar medicines
Reflection paper on a tailored clinical approach in biosimilar development
Reflection paper on a tailored clinical approach in biosimilar development
Human medicines European public assessment report (EPAR): Evista, raloxifene, Date of authorisation: 05/08/1998, Revision: 31, Status: Authorised
RoActemra
IRIS guide to registration and RPIs
Organisation chart: Veterinary Medicines